| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $459.1M | -28.9% |
| Cost of Revenue | $389.0M | -28.5% |
| R&D Expense | $21.1M | +38.7% |
| SG&A Expense | $55.6M | -9.5% |
| Operating Income | -$35.4M | -1746.8% |
| Interest Expense | $9.2M | +18.1% |
| Pre-tax Income | $30.5M | +419.9% |
| Income Tax | $102.9M | +9928.6% |
| Net Income | -$57.7M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.5M | -71.2% |
| Accounts Receivable | $60.0M | -21.2% |
| Current Assets | $80.4M | -41.3% |
| Total Assets | $170.1M | -41.3% |
| Current Liabilities | $76.9M | -8.7% |
| Long-term Debt | $183.1M | -2.0% |
| Total Liabilities | $256.2M | -27.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $28.3M | -1.2% |
| Capital Expenditures | $98K | -84.9% |
| Investing Cash Flow | -$49.8M | -7557.7% |
| Financing Cash Flow | -$14.5M | -1411.0% |
| Free Cash Flow | $28.2M | +0.7% |
| -993.2% |
| EPS (Basic) | -$1.37 | -878.6% |
| EPS (Diluted) | -$1.37 | -621.1% |
| Stockholders' Equity |
| -$16.0M |
| -268.8% |